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We have identified and purified a DNA binding protein which specifically binds to a segment of the mouse a2 (I) collagen promoter between -420 
and -399 bp upstream of the start of transcription. Purification included heparin-agarose and sequence-specific DNA-aflmity chromatography, 
followed by SDS-PAGE and renaturation of the DNA binding activity after elution from SDS-polyacrylamide gel. The DNA binding activity resides 
in two species of 42 kDa and 40 kDa, respectively. The levels of DNA binding activity of this factor, which has been tentatively designated as ColFl, 
are considerably higher in nuclear extracts of NIH-3T3 fibroblasts than in nuclear extracts from epidermal cells, lymphoid cells and transformed 
NIH-3T3 fibroblasts. 
DNA binding factor; Mouse a2 (I) collagen promoter; NIH-3T3 fibroblast 
1. INTRODUCTION 
Type I collagen is a major protein of the extracellular 
matrix present at high concentrations in bones, tendons, 
skin, cornea and in much lesser concentrations in a 
number of other tissues. Changes in the biosynthesis of 
type I collagen occur under several physiological condi- 
tions such as during embryonic development of these 
organs and also during wound healing. Furthermore, 
such changes also occur in a number of pathological 
conditions involving fibrotic lesions of various organs. 
Although translational control [l] has been proposed to 
occur in some situations, transcriptional regulation of 
type I collagen genes plays a major role in the biosyn- 
thesis of this protein [2-61. 
or a factor with similar binding properties binds to a 
sequence between -315 and -295 in the a2 (I) collagen 
promoter [9]. Other &acting elements have been iden- 
tified in these two genes that are binding sites for still 
other specific factors [l l-l 51. Based on mutation analy- 
sis of the DNA binding sites, some of these factors are 
believed to act as positive effecters of transcription 
whereas others appear to have an inhibitory role in 
transcription [l&12]. We report here on the isolation 
and characterization of an additional factor which 
binds to a segment between -419 and -399 bp in the a2 
(I) collagen gene 5’ flanking sequence. 
Several factors present in nuclear extracts of fibrob- 
lasts were previously shown to interact with specific 
DNA sequences in the al (I) and a2 (I) collagen pro- 
moters [7-121. These include a heterodimeric CCAAT 
binding factor (CBF) which binds to a CCAAT motif 
which is located between -96 and -100 in the al (I) 
collagen promoter and between -80 and -84 bp in the 
a2 (I) promoter [7,8,10,12]. We have shown previously 
that CBF activates transcription of both the al (I) and 
a2 (I) collagen promoters in a reconstituted in vitro 
transcription system [lo]. In addition, nuclear factor I 
2. MATERIALS AND METHODS 
2.1. DNA fragments and plasmi& 
The XbaI-XmaI fragment contains the sequence between -504 and 
-105 of the mouse a2 (I) collagen promoter; the Apal-Hind111 frag- 
ment contains the sequence between -105 and +54 in this promoter 
[16]. The plasmid pAH5 was obtained by cloning two 31-mer comple- 
mentary oligonucleotides corresponding to the sequence between 
-394 and -424 of the mouse a2 (I) collagen promoter into the SmaI 
site of plasmid pUC-12. A 72 bp HindIII-EcoRI fragment was pre- 
pared from this recombinant plasmid and also includes surrounding 
polylinker sequences. Labeled restriction fragments for the DNA 
binding assays were prepared by phosphorylation of the 5’ ends using 
T4 polynucleotide kinase and [y-“P]ATP. 
2.2. Preparation of nuclear extracts 
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Japan. Fax: (81) (86) 462-l 199. 
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NIH-3T3 fibroblasts and A431 cells were grown in Dulbecco’s mod- 
ified Eagle’s medium supplemented with 10% newborn calf serum. 
NIH-3T3 cells were transformed by either infection with the Moloney 
murine sarcoma leukemia virus complex (MMSV) or by transfection 
with a plasmid containing the v-ras oncogene. Mouse epidermal cells 
(HEL cells) [17] were grown in Dulbecco’s modified Eagle’s medium 
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with 10% fetal calf serum. A mouse T-lymphocyte cell line kindly 
supplied by Dr. Riethmiiller, University of Munich was grown in 
RPM1 supplemented with 10% FCS and 20 U/ml IL-2. Preparation 
of nuclear extracts for purification of the ColFl binding factor was 
performed as described previously [7] from NIH-3T3 cells except hat 
1 &ml pepstatin A and 0.01% Nonidet P-40 were included in all 
buffers. For detection of binding activity and the exonuclease III assay 
2-6 x lo6 cells were harvested and washed twice with phosphate buffer 
saline at 4°C. The nuclei were isolated according to Groudine et al. 
[I 81. The nuclei were then suspended in 4 ~01s. of 20 mM HEPES, pH 
7.9, 1 mM EGTA, 0.5 mM DTT, 400 mM NaCl, 10% glycerol, 0.01% 
Nonidet P-40, 0.5 mM PMSF, 10 pg/ml leupeptin and 10 pg/ml pep- 
statin A. The mixture was stirred for 30 min at 4’C and centrifuged 
for 10 min in an Eppendorf centrifuge. The supernatants were used 
as nuclear extracts. Protein concentrations were assayed with a Bio- 
Rad kit [19]. 
2.3. Assay of DNA binding proteins 
The exonuclease III assay [20] has been described previously. For 
the gel retardation assay l-3 ~1 of nuclear extracts were incubated for 
20 min at 26°C in 10 ~1 of a mixture containing 20 mM HEPES, pH 
7.5, 0.5 mg/ml bovine serum albumin, 150 mM NaCl, 1 mM EDTA, 
0.5 mM DTT, 4 ~1 of poly(dI-dC) as well as lo4 cpm (approximately 
0.2 ng) of 3*P-labeled DNA fragments. To stop the binding reaction, 
2.0 ~1 of a sample buffer containing 0.1% xylene cyanol, 0.1% 
Bromphenol blue and 20% glycerol was added, and the DNA-protein 
complexes were separated from other components of the mixture by 
electrophoresis on a 6% polyacrylamide gel in TBE (89 mM Tris, 89 
mM boric acid, 8 mM EDTA pH 7.9). The binding activity was 
measured by densitometric scanning of the autoradiograph. In some 
experiments the regions of the gel containing the labelled species were 
cut out and counted by liquid scintillation. 
2.4. PuriJication of the binding factor from NIH-ST3 cells 
A nuclear extract (65 ml) prepared from 40 g (wet weight) of NIH- 
3T3 cells was dialyzed against buffer A containing 20 mM HEPES, 
pH 7.9, 50 mM NaCl, 0.1 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF, 
20% glycerol, 0.01% Nonidet P-40, 1 &ml leupeptin and 1 &ml 
pepstatin A. The dialyzed extract was applied to a column (8 ml) of 
heparin-agarose. The column was washed with 40 ml of buffer A and 
then washed with 11 ml of the same buffer containing 0.35 M NaCI. 
The ColFl binding activity was eluted with 0.75 M NaCl in buffer A. 
This fraction was purified by sequence-specific oligonucleotide affinity 
chromatography [21]. The affinity column consisted of a double- 
stranded oligonucleotide (corresponding to the sequence between 
-394 and -424) covalently linked through a lo-nucleotide long 5’ 
overhang of one DNA strand to CNBr-activated Sepharose4B. The 
active fractions from the heparin-agarose column were pooled, diluted 
IS-fold with NaCl-free buffer A and applied to this DNA-affinity 
column (0.7 ml). The column was then washed with 100 ml of buffer 
A and 100 ml of buffer A containing 0.3 M NaCl. The ColFl binding 
activity was eluted with 1.5 ml of the same buffer containing 1.0 M 
NaCl. The active fractions, diluted in 20 ~01s. of NaCl-free buffer A, 
were reapplied on another column containing the same DNA-affinity 
resin (0.7 ml) and washed with the following volumes of buffer A with 
the indicated concentration of NaCl: SO mM, 100 ml; 150 mM, 100 
ml; 350 mM, 30 ml; 500 mM, 1.5 ml; 0.75 mM, 1.5 ml; 1.0 M, 1.5 ml; 
1.5 M, 1.5 ml. The fractions were analyzed by gel retardation assay 
also by SDS-polyacrylamide gel for silver-staining according to Wray 
et al. [22]. 
2.5. Characterization of the binding factor by FPLC 
Fractions purified once by DNA affinity chromatography were 
applied to an FPLC MonoQ column (Pharmacia) equilibrated with 30 
mM Tris-HCl, pH 7.9, 0.1 mM EDTA, 10% glycerol, 0.01% Nonidet 
P-40, 0.5 mM dithiothreitol, 0.5 mM PMSF, 50 mM NaCl, 1 &ml 
leupeptin, 1 pg/rnl pepstatin A. A 20 ml gradient of 50 to 500 mM 
NaCl in the same buffer was applied for elution. 
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2.6. Renaturatlon of the ColFl factor 
400 ~1 (approximately 4,ug of protein) of the fraction purified once 
on the affinity column was run on an SDS-polyacrylamide gel. The 
protein bands were excised and eluted from the polyacrylamide gel. 
Renaturation was performed according to Briggs et al. [23]. The SDS 
was removed from the protein by acetone precipitation, and the pre- 
cipitated protein was resuspended in 6 M guanidine hydrochloride 
(Gu-HCl) to denature the polypeptide chains. Subsequent removal of 
the Gu-HCl by dialysis allowed refolding of the polypeptide chains 
and recovery of DNA binding activity as determined by the gel retar- 
dation assay. 
3. RESULTS AND DISCUSSION 
In order to identify factors binding to the promoter 
region of the mouse a2 (I) collagen gene, a series of 
fragments spanning the sequences between -990 and 
+54 have been tested by either DNase I or exonuclease 
III footprinting using nuclear extracts isolated from 
mouse NIH-3T3 fibroblasts as a source of DNA bind- 
ing proteins [8]. Using the exonuclease III assay, with 
an XmaI-XbaI fragment between -504 and -10.5 la- 
beled at the XmaI site at -105, a DNA binding factor 
was identified that showed a 5’ boundary of protection 
mapping approximately at -420 (Fig. la). This bound- 
ary was confirmed more precisely by running the four 
Maxam-Giblert sequencing reactions of the same frag- 
ment in parallel to the exonuclease III reaction (data not 
shown). Specificity of binding was established by com- 
petition experiments which demonstrated that increas- 
ing amounts of an unlabeled fragment containing se- 
quences of the a2 (I) collagen promoter between -419 
and -399, decreased the exonuclease III generated sig- 
nal in a dose-dependent manner, whereas the same 
amounts of an unrelated DNA fragment did not com- 
pete for binding (Fig. la). The other boundary (-399) 
of protection against exonuclease III was identified by 
performing a similar assay using the XmaI-XbaI frag- 
ment labeled at the _%%a1 site at -504 (data not shown). 
This DNA binding factor was tentatively designated 
ColFl. Although the exonuclease III assay has the ad- 
vantage of defining the boundaries of the DNA segment 
protected by a DNA binding protein, it cannot be easily 
used for quantitative measurements. We therefore used 
a gel mobility shift assay with a 72 bp HindIII-EcoRI 
DNA fragment of plasmid pAH5 labeled at the Hind111 
site; this 72 bp fragment contains a cloned oligonucleo- 
tide containing the sequence between -419 and -399 of 
the mouse 012 (I) collagen gene within the polylinker of 
pUC-9 (Fig. lb). Specificity of the gel retardation assay 
is indicated by the fact that the signal is competed by 
excess amounts of the unlabeled 72 bp HindIII-EcoRI 
fragment of pAH 5 but not by a control DNA (Fig. lb). 
The effect of temperature on the activity present in the 
crude extract was tested by gel retardation assay. Incu- 
bation at 60°C for five minutes resulted in about 50 
percent loss of activity which was further reduced after 
incubation at 95°C for five minutes (data not shown). 
NIH-3T3 nuclear extracts were first applied to a col- 
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umn of heparin-agarose. The active factor was eluted of DNA binding activity was observed after the second 
with 0.75 M NaCl yielding a 5-fold purification (Table affinity column. A 500-fold purification was obtained 
I). The major purification step was achieved by using with the first and an additional 6- to 7-fold purification 
a DNA affinity column prepared from a double- with the second affinity column (Table I). By silver-stain 
stranded oligonucleotide containing the sequence be- of an SDS-polyacrylamide gel two protein bands of 40 
tween -419 and -399 of the mouse a2 (I) collagen and 42.5 kDa were detected in the fraction eluting at 
promoter (Fig. 2a). When the active heparin-agarose 0.75 M NaCl (Fig. 2~). Additional bands (116 and 55 
fraction was passed through this DNA affinity column, kDa) were also seen but these did not demonstrate ac- 
activity was eluted with a 1 M NaCl step. The active tivity in subsequent renaturation experiments (see 
fractions were then passed a second time over the col- below). The purified fraction was also used in the ex- 
umn which was washed with increasing concentrations onuclease III assay and showed a signal at the -419 
of NaCl. The majority of the binding activity was eluted boundary of binding (data not shown). The active frac- 
with 0.75 M NaCl (Fig. 2b) although a substantial loss tion obtained after the first DNA affinity chromatogra- 
6 
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B 
F 
competitor - -208D3201/28% - - - ng 
controlON - - - - - - 208032Ol,28ong 
Fig. 1. Exonuclease III and gel retardation assay of the ColFl binding 
activity. (A) The upstream border of the binding site of the factor was 
assayed by exonuclease III. The X6aI-XmaI fragment of the mouse 
a2 (I) collagen promoter (-504 to -104), 5’ end-labeled at the XmaI 
site (-104) was incubated with exonuclease III in the absence or 
presence of nuclear extracts from NIH-3T3 cells (2 mg/ml). Competi- 
tor DNA was a 72 bp fragment containing the sequence of the mouse 
a2 (I) collagen gene between -424 and -394. A 41 bp unrelated 
HindIII-EcoRI DNA fragment of pUC 12 was used as control com- 
petitor. Size markers were end-labeled $X174 DNA fragments di- 
gested by ZfueIII. Lanes 1 and 2 have no extraact and each contain 
two different concentrations of exonuclease III. The arrow indicates 
a 5’ boundary of protection mapping at -420. (B) A gel retardation 
assay was performed using 2 pug of protein of a nuclear extract pre- 
pared from NIH-3T3 cells. The labeled fragment is a 72 bp HindIII- 
EcoRI fragment of pAH5 containing the sequence of the mouse a2 (I) 
collagen promoter between -424 and -394 within a polylinker seg- 
ment, 5’ end-labeled at the Hind111 end. B represents the protein DNA 
complex; F free DNA. The indicated amounts of the unlabeled 72 bp 
HindIII-EcoRI fragment of competitor pAH5 or the 41 bp HindIII- 
EcoRI of pUC 12 control DNA were included in the binding reaction 
as marked. 
Table I 
Purification of ColFl from NIH-3T3 cells 
Fraction Volume Protein Specific activity Purification Yield 
(ml) (mg) (unit@g) (fold) (%) 
Nuclear extract 65 118 0.6 1 100 
Heparin-agarose 10 20 3 5 85 
First DNA-affinity 1.5 0.012 1,660 2,767 28 
Second DNA-affinity 1.5 0.0006 11,100 18,500 9 
a One unit is defined as the activity causing retardation of 1% of the labeled fragment under the conditions of our assay. 
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GGCACAGAGTGAAGCGGGACTGGACAGCTCCTGCCTTTTCA 
CTTC_GCCCTGACCTQTCGAGGACG’%AAAAGT 
kD 
August 1993 
c 
:c Second affinity 
C 
Zl I 
Fig. 2. Purification of the ColFl binding factor by sequence-specific DNA-affinity chromatography. (A) Sequences of the 41-mer sense strand and 
the 31-mer anti-sense DNA used for affinity chromatography. The complementary segments of the oligonucieotides correspond to the region from 
-424 to -394 of the mouse a2 (I) collagen promoter. The sequence protected in the exonuclease III assay is underlined. After hybridization to 
each other the double stranded oligonucleotide was coupled to CHBr-activated Sepharose 4B. (B) The fraction eluted after heparin agarose 
chromatography by buffer A containing 0.75 M NaCl, was passed over the affinity column. This fraction was then diluted 20-fold with buffer A 
without NaCl and applied to a second similar column. This column was then washed with buffer A and consequently eluted with buffer A containing 
the indicated concentrations of NaCl. One microliter of the fractions was tested for binding activity of ColFl binding factor using the gel retardation 
assay. B, DNA-protein complex; F, free DNA; FT, flow through. (C)Another portion (30~1) of the fractions was analyzed by SDS-polyacrylamide 
gel and silver staining. The two arrows indicate the position of the 40 and 42.5 kDa bands. 
phy was also applied to an FPLC MonoQ column and 
eluted with a 25 ml linear gradient of NaCl (50 to 500 
mM). The peak of ColFl binding activity was detected 
at approximately 0.4 M, as determined by gel retarda- 
tion assay (Fig. 3A). When these fractions were ana- 
lyzed by silver staining both the 42 kDa and 40.5 kDa 
polypeptides were detected (Fig. 3B). The amounts of 
these polypeptides correlated well with the binding ac- 
tivities seen in the gel retardation assay. The binding 
activity of these purified fractions was also competed by 
the 72 bp HindIII-EcoRI fragments of pAH5 but not 
by an unrelated DNA fragment. 
In order to provide conclusive evidence that the two 
major polypeptide species purified by the DNA affinity 
column bind to the segment between -419 and -399, 
renaturation experiments were performed. The active 
fraction obtained after one passage of DNA affinity 
chromatography was fractionated by electrophoresis on 
an SDS-polyacrylamide gel. The entire gel was cut into 
0.5 cm slices, the proteins were eluted and subjected to 
renaturation. As shown in Fig. 4A only the region con- 
taining both 40 and 42.5 kDa bands exhibited DNA 
binding activity after renaturation. Furthermore, that 
region was then examined more precisely as demon- 
strated in Fig. 3B. Two peaks containing binding activ- 
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ity were found, the first peak contained the 42.5 kDa 
polypeptide and the second peak contained the 40 kDa 
polypeptide (Fig. 4b). The retarded band which corre- 
sponds to the complex formed with the 42.5 kDa pol- 
ypeptide migrates slightly slower than the band corre- 
sponding to the complex formed with the 40 kDa pol- 
ypeptide. 
We wished to compare the levels of ColFl binding 
activity in nuclear extracts from a variety of cell types, 
which had previously been shown to synthesize different 
amounts of type I collagen, As shown in Fig. 5A a three 
to four times reduced level of ColFl binding activity 
was found in v-mos and v-TCIS transfo~ed NIH-3T3 
flbroblast compared to normal NIH-3T3 cells. It was 
shown previously that the level of type I collagen RNA 
is reduced in v-mos and v-pas transformed cells [4]. Sim- 
ilarly a substantial decrease was detected in nuclear 
extracts from epidermal cells and in extracts from lym- 
phocytes. To provide evidence that these differences in 
DNA binding activities were not due to general degra- 
dation of nuclear proteins, we compared the DNA bind- 
ing activities of CBF in nuclear extracts of the same cell 
lines. The results of Fig. 5B show that the extracts of the 
different cell lines did not contain significant differences 
in the levels of CBF binding activity. 
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Fig. 3. Characterization of the binding factor by FPLC. Fractions 
purified once by DNA affinity chromatography were applied to an 
FPLC Mono Q column and eluted with a 25 ml linear gradient of 
NaCl (50 to 500 mM). Fifty fractions were obtained, and ah the 
fractions were dialyzed against buffer A. (A) Three ~1 of samples from 
each fraction were tested for binding activity by the gel retardation 
assay. Lane D, DNA probe only; lane C, the protein sample from the 
first af8nity column. (B) Thirty@ of samples from each fraction were 
analyzed by SDS-~ly~~l~ide gel and silver staining. The two 
arrows indicate the 40 and 42.5 kDa bands. The numbers are the 
fraction numbers. 
Several proteins have previously been identified as 
factors which are likely to regulate transcription of the 
mouse of a2 (I) collagen gene [7-l 11. We report here on 
the properties of another protein which binds to a spe- 
cific site in this promoter. The binding activity of this 
factor is significantly higher in extracts of cells which 
synthesize higher levels of type I collagen. The factor 
present in a nuclear extract from mouse NIK3T3 fi- 
brobfasts protects a segment between -419 and -399 
upstream of the transcription start site of the a2 (I) 
collagen gene. This segment displays an incomplete in- 
verted repeat (5’-GGACTGG/ACAGCTCC-3’) which 
could eventually represent a binding site for two possi- 
ble subunits of a homodimer. Alternatively, the segment 
could simply represent a duplicated site for the same 
binding protein. The specificity of binding was demon- 
strated by the ability of an unlabeled fragment contain- 
ing the same sequence to act as competitor in inhibiting 
binding to the labeled fragment whereas an unrelated 
fragment did not compete. Partial homology was seen 
42.5 40 KDa 
Fig. 4. Renaturation of ColFl binding activity. Four-hundred micro- 
liter aliquots of the fraction purified by one cycle of DNA atlinity 
chromato~aphy were ~n~ntrat~ by 80% acetone pr~ip~tation, re- 
suspended in loading buffer and loaded on two 10% SDS-poly- 
acrylamide gels. In each gel 9110 of the sample was loaded on one lane 
for renaturation experiments, 1110 of the sample was loaded on an- 
other lane for silver staining. (A) After electrophoresis, the entire gel 
lane was cut into 0.5 cm slices. (B) The region around the position of 
slice 8 of gel A was cut into 1 mm slices for slices 1 and 9 and 0.5 mm 
slices for slices 2 to 8. Renaturation was performed as described by 
Briggs et al. [23]. Three @ of renatured protein from each slice were 
tested for binding activity in the gel retardation assay. Lane D, DNA 
probe only: lane C represents a protein sample from the first affinity 
column. 
between this binding site and a segment in the first 
intron of the human steroid Zl-hydroxyla~ B gene [24]. 
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Fig. 5. Gel retardation assay of ColFl binding factor and CCAAT 
binding factor (CBF) using nuclear extracts from different cell lines. 
(A) Indicated amounts of crude nuclear extracts from NIH-3T3 cells, 
v-mos transformed NIH-3T3 cells, v-ras transformed NIH-3T3 cells, 
mouse epidermal cells (HEL cells) and mouse T-lymphocytes (CTLL 
cell) were assayed for binding activity of ColFl binding factor by gel 
retardation assay using the 72 bp ‘*P-labeled HindIII-EcoRI fragment 
of pAH5, S-end labeled at the N~ndIII site. (B) Binding activity of 
CBF in the same nuclear extracts was assayed by gel retardation using 
a 32P-labeled HindHI-ApaI fragment (-105 to +54 of the mouse a2 
(I) collagen promoter) of pAZ 1003. 
No other sequence homologies were found with the 
-419 and -399 sequence in a computer search of avail- 
able gene banks. 
Purification of the factor from NIH-3T3 fibroblast 
nuclear extracts revealed two species with molecular 
weight of 40 and 42.5 kDa, which both exhibited DNA 
binding activity after elution and renaturation from an 
SDS-polyacrylamide gel. Using DNase I or exonuclease 
III footprinting methods, we have previously detected 
discrete binding sites for DNA binding proteins be- 
tween +l and -350 in the a2 (I) collagen promoter, one 
for CBF between -75 and -95, one for an unknown 
factor around -250 and one for NFl around -300. The 
sequences in these binding sites bear no similarities with 
the binding site for ColFl. The chromatographic elu- 
tion pattern of these proteins on heparin agarose are 
also different. Indeed ColFl elutes at somewhat higher 
salt concentrations than CBF and NFl [8,25]. Moreo- 
ver, CBF is a heteromer which can be separated in two 
complementary activities by chromatography on Mono 
Q [8]. After Mono Q chromatography CBF DNA bind- 
ing activity can only be restored if two different frac- 
tions are combined. Separately, the fractions display no 
CBF DNA binding activity, whereas ColFl retains its 
activity after elution from Mono Q. Furthermore, a 
DNA fragment containing the CBF binding site did not 
compete for binding of the ColFl factor to its binding 
site. Finally, in crude extracts CBF is less heat stable 
than the ColFl binding factor. 
In summary, ColFl is a factor which binds to a spe- 
cific site in the promoter of the mouse a2 (I) collagen 
gene. Its DNA binding activity is considerably higher 
in nuclear extracts from NIH-3T3 fibroblasts than in 
similar extracts from lymphoid cells and epithelial cells. 
NIH-3T3 fibroblasts are known to synthesize substan- 
tial amounts of type I collagen whereas the two other 
cell lines do not synthesize type I collagen. cDNA clones 
for ColFl and transcription experiments in vivo and in 
vitro should help in further characterizing the function 
of this factor. 
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